QQ客服 官方微博 反馈留言

	Oral 9-cis retinoid for childhood blindness due to Leber congenital amaurosis caused by RPE65 or LRAT mutations: an open-label phase 1b trial
	Koenekoop Robert K; Sui Ruifang; Sallum Juliana; van den Born L Ingeborgh; Ajlan Radwan; Khan Ayesha; den Hollander Anneke I; Cremers Frans P M; Mendola Janine D; Bittner Ava K
	2014
卷号	384期号:9953页码:1513-20
ISSN号	1474-547X
DOI	10.1016/S0140-6736(14)60153-7
URL标识	查看原文
收录类别	PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6671283
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Koenekoop Robert K,Sui Ruifang,Sallum Juliana,et al. Oral 9-cis retinoid for childhood blindness due to Leber congenital amaurosis caused by RPE65 or LRAT mutations: an open-label phase 1b trial[J],2014,384(9953):1513-20.
APA	Koenekoop Robert K.,Sui Ruifang.,Sallum Juliana.,van den Born L Ingeborgh.,Ajlan Radwan.,...&Saperstein David A.(2014).Oral 9-cis retinoid for childhood blindness due to Leber congenital amaurosis caused by RPE65 or LRAT mutations: an open-label phase 1b trial.,384(9953),1513-20.
MLA	Koenekoop Robert K,et al."Oral 9-cis retinoid for childhood blindness due to Leber congenital amaurosis caused by RPE65 or LRAT mutations: an open-label phase 1b trial".384.9953(2014):1513-20.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。